Mangrove Partners’s Chemed CHE Stock Holding History

Mangrove Partners’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$802K	Buy	1,723 +79	+5%	+$33.2K	0.05%	145
2026 Q1	$621K	Buy	1,644 +286	+21%	+$122K	0.05%	158
2025 Q4	$581K	Buy	+1,358	New	+$591K	0.05%	147

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Mangrove Partners's CHE Position: Q2 2026 in Review

Mangrove Partners increased its Chemed (CHE) stake by 4.8% in Q2 2026, buying an estimated $33.2K and bringing the position to 1,723 shares worth $802K. The position accounts for 0.05% of the portfolio, ranked #145.

Mangrove Partners first reported a position in CHE in Q4 2025 and has held it in 3 quarters since. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Mangrove Partners held 1,723 shares of Chemed worth $802K as of Q2 2026.
Mangrove Partners bought 79 Chemed shares in Q2 2026, an estimated $33.2K.
Chemed made up 0.05% of Mangrove Partners's portfolio in Q2 2026, its #145 holding.
Mangrove Partners first reported a position in Chemed in Q4 2025 and has held it in 3 quarters since.
530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.